Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dexamethasone-cyclophosphamide pulse therapy in pemphigus.

S Kaur1, A J Kanwar

  • 1Department of Dermatology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

International Journal of Dermatology
|June 1, 1990
PubMed
Summary

Dexamethasone-cyclophosphamide pulse therapy offers encouraging results for pemphigus patients, significantly reducing corticosteroid side effects. Lesions healed rapidly, allowing patients to return to work quickly.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Persistent facial discoid dermatosis successfully treated with topical calcipotriol.

Clinical and experimental dermatology·2021
Same author

Comparison of efficacy of cold trypsinization versus warm trypsinization in preparation of autologous non-cultured epidermal cell suspension for treatment of stable vitiligo.

Journal of the European Academy of Dermatology and Venereology : JEADV·2019
Same author

Subcornfal Pustular Dermatosis.

Indian journal of dermatology, venereology and leprology·2017
Same author

Survey of the causes of urticaria.

Indian journal of dermatology, venereology and leprology·2017
Same author

What is your diagnosis.

Indian journal of dermatology, venereology and leprology·2017
Same author

Peyroniie's Disease.

Indian journal of dermatology, venereology and leprology·2017

Area of Science:

  • Dermatology
  • Immunology
  • Pharmacology

Background:

  • Pemphigus is a rare autoimmune blistering disease affecting the skin and mucous membranes.
  • Conventional corticosteroid therapy for pemphigus often leads to significant side effects.
  • Novel therapeutic strategies are needed to improve pemphigus management and patient outcomes.

Purpose of the Study:

  • To evaluate the efficacy and safety of dexamethasone-cyclophosphamide pulse therapy in patients with pemphigus.
  • To assess the impact of this regimen on lesion healing and patient quality of life.
  • To explore the potential of this pulsed therapy as an alternative to continuous corticosteroid treatment.

Main Methods:

  • Fifty patients diagnosed with pemphigus (45 pemphigus vulgaris, 5 pemphigus foliaceus) were enrolled.

Related Experiment Videos

  • Treatment involved monthly intravenous dexamethasone (136 mg) and cyclophosphamide (500 mg) pulses over 3 consecutive days.
  • Patients received daily oral cyclophosphamide (50 mg) between pulses.

    • Main Results:

    • The dexamethasone-cyclophosphamide pulse therapy demonstrated encouraging outcomes in pemphigus patients.
    • A key advantage observed was the significant reduction in corticosteroid-related side effects.
    • Rapid healing of pemphigus lesions was noted within 3-4 days, with patients resuming work within a week.

    Conclusions:

    • Dexamethasone-cyclophosphamide pulse therapy presents a promising treatment option for pemphigus.
    • This regimen offers a favorable safety profile compared to traditional corticosteroid treatments.
    • The rapid clinical improvement suggests a potential for enhanced patient recovery and quality of life.